PARP1 inhibitors can also enhance the efficacy of radiotherapy, alkylating agents, and platinum‐based chemotherapy by inhibiting DNA repair and promoting apoptosis in tumour cells.13 This evidence concerns the gene PARP1 and neoplasm.